Thus, this study aims to assess whether significant alterations in erythrogram indicators and CRP levels in ICU patients with acute respiratory syndrome related to COVID-19 can serve as effective prognostic biomarkers for severe outcomes. This evidence concerns the gene CRP and COVID-19.